chlormadinone acetate has been researched along with Atrophy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aparicio, H; Carranza-Lira, S; Fragoso-Díaz, N; Garduño-Hernández, MP; MacGregor-Gooch, AL; Ríos-Calderón, K | 1 |
Ikeda, R; Murakoshi, M; Tagawa, M | 1 |
Fukui, N; Ikeda, R; Murakoshi, M; Nakayama, T | 1 |
3 other study(ies) available for chlormadinone acetate and Atrophy
Article | Year |
---|---|
Vaginal dryness assessment in postmenopausal women using pH test strip.
Topics: Atrophy; Chlormadinone Acetate; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydrogen-Ion Concentration; Medroxyprogesterone; Middle Aged; Pain Measurement; Postmenopause; Predictive Value of Tests; Vagina; Vaginal Diseases | 2003 |
Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Animals; Atrophy; Chlormadinone Acetate; Dogs; Immunohistochemistry; Isoenzymes; Male; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Androgen | 2000 |
Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Topics: Androgen Antagonists; Animals; Apoptosis; Atrophy; Chlormadinone Acetate; Dogs; Male; Progesterone Congeners; Prostate; Prostatic Hyperplasia | 2001 |